Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Caffeine Therapy for Hypoxia in Preterm Neonates: A Randomized Trial Assessing Efficacy, Acute Kidney and Brain Injury, Safety, and Pharmacokinetics

NCT07262060 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT07262060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Caffeine Therapy for Hypoxia in Preterm Neonates: A Randomized Trial Assessing Efficacy, Acute Kidney and Brain Injury, Safety, and Pharmacokinetics
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 2
Overall status
Recruiting
Start date
May 28, 2026
Completion date
September 30, 2030
Enrollment
114 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney injury, pre-term